首页> 外文期刊>Biochimica et Biophysica Acta. General Subjects >Isolation, characterization and mode of neutralization of a potent antihemorrhagic factor from the serum of the snake Bothrops asper
【24h】

Isolation, characterization and mode of neutralization of a potent antihemorrhagic factor from the serum of the snake Bothrops asper

机译:从蛇Botrops asper血清中分离出强效抗出血因子的分离,鉴定和中和方式

获取原文
获取原文并翻译 | 示例
       

摘要

A potent antihemorrhagic factor (BaSAH1) was isolated from the serum of the snake Bothrops asper by ammonium sulfate precipitation at 40–60%, Sephacryl S-200 and Sephadex G-50 gel filtration, DEAE-Sepharose, and hydrophobic Phenyl-Sepharose chromatography. The purified protein showed one band with an isoelectric point of 5.2 and a molecular weight of 66 kDa. 4 μg of the purified factor BaSAH were needed to neutralize the hemorrhagic dose of B. asper whole venom compared to 60 μg of the clinically used horse polyvalent immunoglobulins. Moreover, 0.35 μg of BaSAH were sufficient to achieve complete neutralization of the main hemorrhagic toxin (BaH1), with a molar ratio of 2:1. The antihemorrhagic activity was stable between pH 1.5–9 and up to 60°C but lost activity completely after 30 min of heating at 70°C. BaSAH did not digest the hemorrhagic toxin BaH1 or formed a precipitin line with it, nor with the whole venom. Both ELISA experiments and chromatography of BaSAH after incubation with the 125I-labeled hemorrhagic toxin BaH1 demonstrated that the mechanism of the neutralization involves a formation of an inactive soluble complex between the natural antihemorrhagin and the main hemorrhagin of B. asper venom.
机译:通过以40-60%的硫酸铵沉淀,Sephacryl S-200和Sephadex G-50凝胶过滤,DEAE-Sepharose和疏水性Phenyl-Sepharose色谱法从蛇the草的血清中分离出有效的抗出血因子(BaSAH1)。纯化的蛋白质显示出一条带,其等电点为5.2,分子量为66 kDa。与60μg临床上使用的马多价免疫球蛋白相比,需要4μg的纯化因子BaSAH来中和出血剂量的B. asper整个毒液。此外,0.35μg的BaSAH足以以1:1的摩尔比完全中和主要出血毒素(BaH1)。抗出血活性在pH 1.5–9和最高60°C之间稳定,但在70°C加热30分钟后完全丧失活性。 BaSAH不会消化出血性毒素BaH1或与之形成沉淀蛋白线,也不会与整个毒液形成沉淀蛋白线。 ELISA实验和与125I标记的出血性毒素BaH1孵育后的BaSAH色谱分析均表明,中和机制涉及天然抗出血血红素和B. asper毒液的主要出血凝血素之间形成无活性的可溶性复合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号